T. Arledge

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

Philip J. Mease, Roy Fleischmann, Atul Deodhar et al. · Annals of the Rheumatic Diseases · 2013 · 458 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +6

Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

D. van der Heijde, Roy Fleischmann, J. Wollenhaupt et al. · Annals of the Rheumatic Diseases · 2013 · 77 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Salmeterol does not cause tolerance during long-term asthma therapy

T. Arledge, Roger F. Liddle, Thomas H. Rossing · Journal of Allergy and Clinical Immunology · 1996 · 16 citations

Medicine, Internal Medicine, Pharmacology +7

Effect of Certolizumab Pegol On Signs and Symptoms of Ankylosing Spondyltitis and Non-Radiographic Axial Spondyloarthritis : 24 Week Results of a Double Blind Randomized Placebo-Controlled Phase 3 Axial Spondyloarthritis Study

Robert Landewé, Martín Rudwaleit, Désirée van der Heijde et al. · Data Archiving and Networked Services (DANS) · 2012 · 12 citations

Medicine, Clinical Sciences, Internal Medicine +7